CITIGROUP INC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$5,688
-91.2%
406
-93.5%
0.00%
Q2 2023$64,418
-87.3%
6,224
-88.7%
0.00%
Q1 2023$507,368
+4.7%
54,910
+0.5%
0.00%
Q4 2022$484,435
+16047.8%
54,615
+16400.0%
0.00%
Q3 2022$3,000
-50.0%
331
-55.3%
0.00%
Q2 2022$6,000
-45.5%
741
-39.6%
0.00%
Q1 2022$11,000
-79.2%
1,227
-78.1%
0.00%
Q4 2021$53,000
-8.6%
5,612
+63.0%
0.00%
Q3 2021$58,000
+65.7%
3,443
+49.4%
0.00%
Q2 2021$35,000
+2.9%
2,305
+33.2%
0.00%
Q1 2021$34,000
-57.5%
1,731
-60.9%
0.00%
Q4 2020$80,000
+86.0%
4,426
+96.4%
0.00%
Q3 2020$43,000
-76.5%
2,253
-67.8%
0.00%
Q2 2020$183,000
+51.2%
7,004
+3.6%
0.00%
Q1 2020$121,000
-32.8%
6,759
+25.6%
0.00%
Q4 2019$180,000
+414.3%
5,383
+258.4%
0.00%
Q3 2019$35,000
-83.0%
1,502
-73.8%
0.00%
Q2 2019$206,000
+1772.7%
5,732
+1761.0%
0.00%
Q1 2019$11,0003080.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders